Extension of ischemic therapeutic time window by a free radical scavenger, Edaravone, reperfused with tPA in rat brain.
about
Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neuronsPhosphodiesterase-III inhibitor prevents hemorrhagic transformation induced by focal cerebral ischemia in mice treated with tPASynergy of combined tPA-edaravone therapy in experimental thrombotic strokeRecombinant Tissue Plasminogen Activator Induces Neurological Side Effects Independent on Thrombolysis in Mechanical Animal Models of Focal Cerebral Infarction: A Systematic Review and Meta-AnalysisProphylactic Edaravone Prevents Transient Hypoxic-Ischemic Brain Injury: Implications for Perioperative Neuroprotection.Acute enoxaparin treatment widens the therapeutic window for tPA in a mouse model of embolic stroke.Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury.A novel finding of a low-molecular-weight compound, SMTP-7, having thrombolytic and anti-inflammatory effects in cerebral infarction of miceThe contribution of L-arginine to the neurotoxicity of recombinant tissue plasminogen activator following cerebral ischemia: a review of rtPA neurotoxicityStriatal neuroprotection from neonatal hypoxia-ischemia in piglets by antioxidant treatment with EUK-134 or edaravone.Improved brain MRI indices in the acute brain stem infarct sites treated with hydroxyl radical scavengers, Edaravone and hydrogen, as compared to Edaravone alone. A non-controlled study.The Relation of Urinary 8-OHdG, A Marker of Oxidative Stress to DNA, and Clinical Outcomes for Ischemic Stroke.Cerebral revascularization by endovascular techniques.Does inhibiting Sur1 complement rt-PA in cerebral ischemia?17β-estradiol attenuates breakdown of blood-brain barrier and hemorrhagic transformation induced by tissue plasminogen activator in cerebral ischemia.Clinical predictors and management of hemorrhagic transformation.Edaravone improves functional and structural outcomes in animal models of focal cerebral ischemia: a systematic review.Phase II anti-inflammatory and immune-modulating drugs for acute ischaemic stroke.Pericyte protection by edaravone after tissue plasminogen activator treatment in rat cerebral ischemia.Vascular protection and restorative therapy in ischemic stroke.Thrombolysis with Low-Dose Tissue Plasminogen Activator 3-4.5 h After Acute Ischemic Stroke in Five Hospital Groups in Japan.Is there potential for antioxidants to enhance thrombolysis therapy in patients with ischemic stroke?Edaravone (Radicut), a free radical scavenger, is a potentially useful addition to thrombolytic therapy in patients with acute ischemic stroke.Pre-treatment with the synthetic antioxidant T-butyl bisphenol protects cerebral tissues from experimental ischemia reperfusion injury.Albumin ameliorates tissue plasminogen activator-mediated blood-brain barrier permeability and ischemic brain injury in rats.Dissociation and protection of the neurovascular unit after thrombolysis and reperfusion in ischemic rat brain.The novel antioxidant edaravone: from bench to bedside.Endogenous tissue plasminogen activator increases hemorrhagic transformation induced by heparin after ischemia reperfusion in rat brains.
P2860
Q21262040-53567BD3-B595-4A47-A5BE-66DF6FC5B3E8Q28476434-2D743F17-8CAD-4902-9AF0-6A2E82A2DF1CQ28539510-F0EC617C-5CCF-49A4-A8D5-8E35682E40A4Q28552445-FBCDBFA0-1B67-4858-A0A6-1FEB04198CDFQ30968894-7944F360-A4E4-41F7-A74C-F8CB5DDE3D28Q33286104-9FBE4931-93C7-40E9-AF54-BB48D53E5C07Q33997543-1BE37C78-C0AE-419B-8AB9-50737A1A00E1Q34079940-A5334A84-60FF-476C-A9A9-C292B6E40E4BQ34504984-25E5AE08-920A-4F75-9568-55A43BF1E425Q35576397-B6384988-CA4B-4413-B48B-9AB7F7EF1B4AQ35596149-A5EF8237-FBD8-425E-900D-C0992E9BA0E1Q36067314-508BC5F6-99B5-4659-8BCC-58FE4C504004Q36273716-A159F314-9D47-440D-985E-E00D4E8897D5Q36426567-9A454340-4F91-456A-8B23-09EE12ACA8C0Q36555588-E946AD90-CB2F-4391-A72E-2683095D3DC3Q38074569-C6455E48-4307-4F6B-9B1F-5D594FDE9440Q38154741-1893E0D9-9DFC-49D1-8979-8287461A3E24Q38366399-6ACC9BDA-2E39-4E51-9E48-A0CA3C357D99Q38983792-FBED5871-0814-4629-8E2B-0610AF9EE0F1Q39831672-E20CDCB5-E5D5-4ADD-88EB-F27073606888Q40056448-C65BB8A5-9504-4496-ABF0-7FCA0AAE192EQ40274650-2A26D9B6-8A5B-4653-B03D-CB77CE0B4720Q42408578-C1C37C3C-8A3D-4FFC-9059-6B31CDB4E509Q44439469-2B686E14-A218-45D4-9035-07728AF1166CQ46082556-8CC24B5C-953E-4048-BFBA-271A060B1836Q46164241-2006C38B-1ED8-4D42-ADD2-3960E4467B83Q46591722-A6C8BF61-237C-410A-8AEB-43C9CFE69AB5Q48691531-E1FF88AB-BE68-45F5-B2DD-BA3F9C5D4BF4
P2860
Extension of ischemic therapeutic time window by a free radical scavenger, Edaravone, reperfused with tPA in rat brain.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Extension of ischemic therapeu ...... erfused with tPA in rat brain.
@en
Extension of ischemic therapeu ...... erfused with tPA in rat brain.
@nl
type
label
Extension of ischemic therapeu ...... erfused with tPA in rat brain.
@en
Extension of ischemic therapeu ...... erfused with tPA in rat brain.
@nl
prefLabel
Extension of ischemic therapeu ...... erfused with tPA in rat brain.
@en
Extension of ischemic therapeu ...... erfused with tPA in rat brain.
@nl
P2093
P2860
P1476
Extension of ischemic therapeu ...... erfused with tPA in rat brain.
@en
P2093
Isao Nagano
Keiko Sato
Nobuhiko Omori
Seikoh Horiuchi
Shinsuke Kato
Takeshi Hayashi
Wenri Zhang
P2860
P304
P356
10.1179/016164104225014058
P577
2004-04-01T00:00:00Z